Literature DB >> 6942645

Importance of potassium in patients with acute myocardial infarction.

R J Solomon, A G Cole.   

Abstract

The records of 151 patients entering a coronary care unit and subsequently diagnosed as having an acute myocardial infarction were reviewed. The prevalence of hypokalemia, its relationship to diuretic treatment and the development of either ventricular tachycardia or ventricular fibrillation were studied. At admission, 14% of patients were hypokalemic. The presence of hypokalemia was related to previous diuretic therapy. Twenty-three percent of patients receiving diuretics as compared to 7% of patients not taking diuretics had a serum potassium of 3.5 mEq/L or less. Thirty-seven patients experienced either ventricular tachycardia or ventricular fibrillation. The presence of hypokalemia was associated with an increased frequency of both of these arrhythmias. Sixty-seven percent of patients with a serum potassium of less than 3.1 mEq/L had these serious ventricular arrhythmias compared to 40% of patients with a serum potassium between 3.1 and 3.5 mEq/L and 20% of normokalemic patients. The prevalence of premature ventricular beats was not correlated with the presence of hypokalemia. We conclude that hypokalemia is not only a common problem in patients with acute myocardial infarction but a clinically significant factor in the development of life threatening arrhythmias. Primary prevention of hypokalemia and its prompt treatment are indicated in these patients.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6942645     DOI: 10.1111/j.0954-6820.1981.tb02643.x

Source DB:  PubMed          Journal:  Acta Med Scand Suppl        ISSN: 0365-463X


  18 in total

1.  Acute coronary syndromes. Challenging accepted post-MI serum potassium targets.

Authors:  Sean van Diepen; Christopher B Granger
Journal:  Nat Rev Cardiol       Date:  2012-02-28       Impact factor: 32.419

2.  The impact of serum potassium-influencing antihypertensive drugs on the risk of out-of-hospital cardiac arrest: A case-control study.

Authors:  Fawaz F Alharbi; Patrick C Souverein; Mark C H de Groot; Marieke T Blom; Anthonius de Boer; Olaf H Klungel; Hanno L Tan
Journal:  Br J Clin Pharmacol       Date:  2017-08-16       Impact factor: 4.335

3.  Serum Potassium, Mortality, and Kidney Outcomes in the Atherosclerosis Risk in Communities Study.

Authors:  Yan Chen; Alex R Chang; Mara A McAdams DeMarco; Lesley A Inker; Kunihiro Matsushita; Shoshana H Ballew; Josef Coresh; Morgan E Grams
Journal:  Mayo Clin Proc       Date:  2016-08-04       Impact factor: 7.616

4.  Pre-treatment with beta blockers and the frequency of hypokalaemia in patients with acute chest pain.

Authors:  E Simpson; J C Rodger; S M Raj; C Wong; L Wilkie; C Robertson
Journal:  Br Heart J       Date:  1987-11

5.  Serum potassium levels, cardiac arrhythmias, and mortality following non-ST-elevation myocardial infarction or unstable angina: insights from MERLIN-TIMI 36.

Authors:  Ravi B Patel; Sara Tannenbaum; Ana Viana-Tejedor; Jianping Guo; KyungAh Im; David A Morrow; Benjamin M Scirica
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2016-09-20

Review 6.  Endocrine physiology of electrolyte metabolism.

Authors:  K G Dawson
Journal:  Drugs       Date:  1984-10       Impact factor: 9.546

7.  Arrhythmogenic potential of diuretic induced hypokalaemia in patients with mild hypertension and ischaemic heart disease.

Authors:  D E Stewart; H Ikram; E A Espiner; M G Nicholls
Journal:  Br Heart J       Date:  1985-09

Review 8.  Electrolyte abnormalities and ventricular arrhythmias.

Authors:  P V Caralis; E Perez-Stable
Journal:  Drugs       Date:  1986       Impact factor: 9.546

9.  Ventricular arrhythmias in patients with myocardial infarction and ischaemia. The role of serum potassium.

Authors:  R J Solomon
Journal:  Drugs       Date:  1986       Impact factor: 9.546

10.  Ventricular extrasystoles during thiazide treatment: substudy of MRC mild hypertension trial.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.